Biochemiczne mechanizmy prozdrowotnego oddzialywania wielonienasyconych kwasow tluszczowych na stan zdrowia czlowieka

• Autorzy: Pisulewski P M , Achremowicz K. , Kostogrys R.B. , Franczyk M.

Warianty tytułu

EN

Biochemical mechanisms of health-related effects of polyunasaturated fatty acids on human health

• Języki publikacji: PL

Abstrakty

EN

Effects of dietary fat on the incidence of major civilization diseases, e.g. Obesity, cardiovascular diseases and cancers were presented. It was emphasised that the absolute amount of fat consumed is less important than is the type of fat, i.e. relative share of saturated (SFA), monounsaturated (MUFA), and polyunsaturated (PUFA) fatty acids. Health-related beneficial effects of MUFA and PUFA were underlined, including the importance of the ratio of n-6: n-3 PUFA. Major health-related effects of PUF A and also CLA (mainly resulting from animal studies) were described. In order to elucidate the mechanisms of PUFA and CLA action, anti-inflammatory properties of these compounds were analysed. Moreover, the prevention of chronic inflammation by PUFA and CLA was considered tobe the major mechanism of their anti-atherogenic and anti-carcinogenic effects. Finally, the current nutritional guidelines related to fat and PUFA consumption were summarized.

Słowa kluczowe

PL

zdrowie czlowieka; miazdzyca; wlasciwosci; stany zapalne; mechanizm dzialania; choroby cywilizacyjne; biochemia; nowotwory; oddzialywanie; zywnosc funkcjonalna; kwasy tluszczowe wielonienasycone; profilaktyka; zywienie czlowieka; sprzezony kwas linolowy

• Wydawca: -
• Czasopismo: Postępy Nauk Rolniczych
• Rocznik: 2005
• Tom: 52
• Numer: 6
• Opis fizyczny: s.101-116,rys.,biblogr.

Twórcy

autor

Pisulewski P M

• Akademia Rolnicza im.H.Kollataja w Krakowie, ul.Balicka 122, 30-149 Krakow

autor

Achremowicz K.

autor

Kostogrys R.B.

autor

Franczyk M.

Bibliografia

• [1] Adlof R.O., Duval S., Emken E.A. 2000. Biosynthesis of conjugated linoleic acid in humans. Lipids 35: 131-135.
• [2] Balkwill F., Coussens L.M. 2004. An inflammatory link. Nature 431: 405-406.
• [3] Baranowski M., Górski J. 2003. Rola receptorów aktywowanych przez proliferatory peroksyzomów (PPAR) w fizjologii i patologii serca. Czynniki Ryzyka 4/02-1103: 40-48.
• [4] Bartnikowska E., Obiedziński M. 1997. Unsaturated trans fatty acids - nutritional problem? Pol. J. Food Nutr. Sci. 6/47(3): 4-24.
• [5] Belury M.A. 2002. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J. Nutr. 132: 2995-2998.
• [6] Blankson H., Stakkestad J.A., Fagertun H., Thom E., Wadstein J., Gudmundsen O. 2000. Conjugated linoleic acid reduced body fat mass in overweight and obese humans. J. Nutr. 130: 2943-2948.
• [7] Bonetti P.O., Lerman L.O., Lerman A. 2003. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vase. Biol. 23: 168-175.
• [8] Bray G.A. 2002. The underlying basis for obesity: relationship to cancer. J. Nutr. 132: 3451 S-3455S.
• [9] Burdge G.C., Jones A.E., Wootton S.A. 2002. Eicosapentaenoic and docosapentaenoic acids are the principal products of α-linoleic acid metabolism in young men. Brit. J. Nutr. 88: 355-363.
• [10] Burdge G.C., Wootton S.A. 2002. Conversion of α-linoleic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Brit. J. Nutr. 88: 411-420.
• [11] Calder P.C. 2002. Dietary modification of inflammation with lipids. Proc. Nutr. Soc. 61: 345-358.
• [12] Calder P.C., Yaqoob P., Thies F., Wallance F.A., Miles E.A. 2002. Fatty acid and lymphocyte function. Brit. J. Nutr. 87, Suppl. 1: S31-S48.
• [13] Camielli V.P., Verlato G., Pederzini F., Luijendijk I., Boerlage A., Pedrotti D., Sauer P.J. 1998. Intestinal absorption of long chain polyunsaturated fatty acids in pre-term infants fed breast milk or formula. Am. J. Clin. Nutr. 67: 97-103.
• [14] Cesano A., Visonneau S., Scimeca J.A. 1998. Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res. 18: 833-838.
• [15] Changhua L., Jindong Y., Defa L., Lidan Z., Shiyan Q., Jianjun X. 2005. Conjugated linoleic acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide. J. Nutr. 135: 239-244.
• [16] Chłopicki S, Gryglewski RJ. 2004. Endothelial secretory function and atherothrombosis. W: ,,The Eicosanoids", wyd. P. Curtis-Prior (John Wiley and Sons, Ltd), rozdział 23: 267-276.
• [17] Chłopicki S, Gryglewski RJ. 2004. Dysfunkcja śródbłonka w cukrzycy- przyczyna rozwoju atherothrombosis. W: ,,Cukrzyca i serce", red. K. Kawecka-Jaszcz, M.Tendera, D. Czarnecka (Via Medica) rozdział ł: 1-19.
• [18] Chłopicki S. 2003. Śródbłonek w farmakoterapii atherothrombosis. Kardiologia Polska 59 (supl. II): 62-69.
• [19] Christon R.A. 2003. Mechanisms of action of dietary fatty acids in regulating the activation of vascular endothelial cells during atherogenesis. Nutr. Rev. 61(8): 272-279.
• [20] Clarke S.D.2001. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J. Nutr. 131. 1129-1132.
• [21] Colandre M.E., Diez R.S., Bernal C.A. 2003. Metabolie effects of trans fatty acids in an experimental dietary model. Brit. J. Nutr. 89: 631-638.
• [22] Connor W.E. 2000. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71: 171S-175S.
• [23] Coussens L.M., Werb Z. 2002. Inflammation and cancer. Nature 420: 860-867.
• [24] Delarue J., LeFoll C., Corporeau C., Lucas D. 2004. n-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod. Nutr. Dev. 44: 289-299.
• [25] Friedenreich Ch.M., Orenstein M.R. 2002. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J. Nutr. 132: 3456S-3464S.
• [26] Gaullier J.M., Halse J., Hoye K., Kristiansen K., Fagertun H., Vik H., Gudmundsen 0. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am. J. Clin. Nutr. 79: 1118-1125.
• [27] Grimm H., Mayer K., Mayser P., Eigenbrodt E. 2002. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Brit. J. Nutr. 87, Suppl. 1: S59-S67.
• [28] Guzik T.J., Adamek-Guzik T., Jopek A., Korbut R. 2004. Patomechanizmy dysfunkcji śródbłonka naczyniowego w miażdżycy. Czynniki Ryzyka 1-2/04: 8-22.
• [29] Hardman W.E. 2002. Omega-3 fatty acids to augment cancer therapy. J. Nutr. 132: 3508S-3512S.
• [30] Hausknecht K.L., van den Heuvel J.P., Moya-Camarena S.Y., Portocarrero C.P., Peck L.W., Nickel L.W., Belury K.P. 1998. Dietary conjugated linoleic acid nonnalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Bioch. Biophys. Res. Comm. 244: 678-682.
• [31] Hayek M.G., Han S.N., Wu D. 1999. Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCrlBR mice. J. Nutr. 129: 32-38.
• [32] Ip C. 1997. Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am. J. Clin. Nutr. 66 (suppl): 1523S-1529S.
• [33] ISSFAL 2004. Report of the Sub-Committee on Recommendations for Intake of Polyunsaturated Fatty Acids in Healthy Adults. Internet: http://issfal.org.uk/adequateintakes.htm.
• [34] Jeznach M. 2003. Stan i perspektywy rozwoju rynku żywności funkcjonalnej. Wydawnictwo SGGW. Warszawa:. 16-42.
• [35] Jiang J., Wolk A., Vessby B. 1999. Relation between the intake of milk fat and the occurrence of conjugated linoleic acid in human adipose tissue. Am. J. Clin. Nutr. 70: 21-27.
• [36] Kepler C.R., Hirons K.P., McNeill J.J. 1966. Intermediates and products of the biohydrogenation of linoleic acid by Butyrivibrio fibrisolvens. J. Biol. Chem. 241: 1350-1354.
• [37] Kersten S. 2002. Effects of fatty acids on gene expression: role of peroxisome proliferator activated receptor α, liver X receptor a and sterol regulatory element binding protein - 1 c. Proc. Nutr. Soc. 61: 371-374.
• [38] Kew S., Gibbons E.S., Thies F., Mc Neil G.P., Quinlan P.T., Calder P.C. 2003. The effect of feeding structured triacylglycerols enriched in eicosapentaenoic or docosahexaenoic acids on murine splenocyte fatty acid composition and leucocyte phagocytosis. Brit. J. Nutr. 90: 1071-1080.
• [39] Kitamoto S., Egashira K. 2004. Endothelial dysfunction and atherosclerosis. Curr. Drug Targ. Cardiovasc. & Haemat. Disord. 4: 13-22.
• [40] Knekt P., Jarvinen R., Seppanen R. 1996. Intake of dairy products and the risk of breast cancer. Br. J. Canc. 73: 687-691.
• [41] Kris-Etherton P.M., Hecker K.D., Binkoski A.E. 2004. Polyunsaturated fatty acids and cardiovascular health. Nutr. Rev. 62(11): 414-426.
• [42] Kritchevsky D. 2000. Antimutagenic and some other effects of conjugated linoleic acid. Brit. J. Nutr. 83: 459-465.
• [43] Lawson R.E., Moss A.R., Givens D.I. 2001. The role of dairy products in supplying conjugated linoleic acid to man's diet: a review. Nutr. Res. Rev. 14: 153-172.
• [44] Leitzmann M.F., Stampfer M.J., Michaud D.S., Augustsson K., Colditz G.C., Willett W.C., Giovannucci E.L. 2004. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am. J. Clin. Nutr. 80: 204-216.
• [45] Lopez-Garcia E., Schulze M.B., Manson J.E., Meigs J.B., Albert Ch.M., Rifai N., Willett W.C., Hu F.B. 2004. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J. Nutr. 134: 1806-1811.
• [46] Lopez-Garcia E., Schulze M.B., Meigs J.B., Manson J.E., Rifai N., Stampfer M.J., Willet W.C., Hu F.B. 2005. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 135: 562-566.
• [47] Lovegrove J. A. 2002. Obesity, body fat distribution and breast cancer. Nutr. Res. Rev. 15: 389-412.
• [48] Maloney F., Yeow T-P., Mullen A., Nolan J.J., Roche H.M. 2004. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am. J. Clin. Nutr. 80: 887-895.
• [49] Mozaffarian D., Rimm E.B., King l.B., Lawler R.L., McDonald G.B., Levy W.C. 2004. Trans fatty acids and systemic inflammation in heart failure. Am. J. Clin. Nutr. 80: 1521-1525.
• [50] McGuire M.K., Park Y.S., Behere R.A., Harrison L.Y., Shultz T.D., McGuire M.A. 1997. Conjugated linoleic acid concentrations of human milk and infant formula. Nutr. Res. 17(8): 1277-1283.
• [51] Müller H., Lindman A.S., Brantsaeter A.L., Pedersen J.I. 2003. The serum LDL/HDL cholesterol ratio is influenced more favorably by exchanging saturated with unsaturated fat than by reducing saturated fat in the diet of women. J. Nutr. 133: 78-83.
• [52] Naruszewicz M. 2000. Miażdżyca - przewlekły stan zapalny śródbłonka tętnic. Czynniki Ryzyka Supl. 7: 9-10.
• [53] Noone E.J., Roche H.M. Nugent A.P., Gibney M.J. 2002. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Brit. J. Nutr. 88: 243-251.
• [54] Nugent A.P., Noone E.J., Gibney M.J. 2001. Conjugated linoleic acid affects Th-1 derived but not Th-2 derived cytokines in healthy human volunteers. Proc. Nutr. Soc. 60: 147A.
• [55] Nugent C., Prins J.B., Whitehead J.P., Wewntworth J.M., Chatterjee V. Krishna K., O'Rahillly S. 2001. Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membranes. J. Biol. Chem. 276: 9149-9157.
• [56] Pariza M.W., Ashoor S.H., Chu F.S. 1979. Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett. 7: 63-69.
• [57] Pariza M.W., Hargraves W.A. 1985. A beef-derived mutagenesis modulator inhibits inhalation of mouse epidermal tumors by 7,12-dimethylbenz(a)anthracene. Carcinogenesis 6: 591-593.
• [58] Riserus U., Amer P., Brismar K., Vessby B. 2002. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese man with the metabolic syndrome. Diabetes Care 25: 1516-1521.
• [59] Riserus U., Vessby B., Arnlov J., Basu S. 2004a. Effects of cis-9, trans-11 conjugated Iinoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese man. Am. J. Clin. Nutr. 80: 279-283.
• [60] Riserus U., Smedman A., Basu S., Vessby B. 2004b. Metabolic effects of conjugated linoleic acid in humans: The Swedish experience. Am. J. Clin. Nutr. 79: l l 46S-l l 48S.
• [61] Roche H.M., Noone E., Nugent A. 2001. Conjugated linoleic acid: a novel therapeutic nutrient? Nutr. Res. Rev. 14: 173-187.
• [62] Rose D. P. 1997. Dietary fatty acids and cancer. Am. J. Clin. Nutr. 66 (suppl): 998S-1003S.
• [63] Ross R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340: 115-126.
• [64] Schonberg S., Krokan H.E. 1995. The inhibitory effect of conjugated dienoic derivatives (CLA) of linoleic acid on the growth of human tumor cell lines is in part due to increased lipid peroxidation. Anticancer Res. 15: 1241-1246.
• [65] Schulz T.D, Chew B.P, Seaman W.R. 1992. Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells. Cancer Lett. 63: 125-133.
• [66] Simopoulos A.P. 1999. Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr. 70 (suppl): 560S-569S.
• [67] Suganuma M., Okabe S., Kurusu M., Iida N., Ohshima S., Saeki Y., Kishimoto T., Fujiki H. 2002. Discrete roles of cytokines, TNF-α, IL-1 , IL-6, in tumor promotion and cell transformation. Inter. J. Oncol. 20: 131-136.
• [68] Suk H.J., Ridker P.M., Cook N.R., Zee R.Y.L. 2005. Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178: 139-145.
• [69] Tanmahasamut P., Liu J., Hendry L.B., Sidell N. 2004. Conjugated linoleic acid blocks estrogen signaling in human breast cancer cells. J. Nutr. 134: 674-680.
• [70] Thies F., Nebe-von-Caron G., Powell J.R., Yaqoob P., Newsholme E.A., Calder P.C. 2001. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subject aged >55y. Am. J. Clin. Nutr. 73: 539-548.
• [71] Tricon S., Burdge G.C., Kew S., Banerjee T., Russell J.J., Grimble R.F., Williams Ch.M., Calder P.C. Yaqoob P. 2004. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am. J. Clin. Nutr. 80: 1626-1633.
• [72] Turek J.J., Yong L., Schoenlein I.A., Allen K.G.D., Watkins B.A. 1998. Modulation of macrophage cytokine production by conjugated linoleic acids is influenced by the dietary n-6:n-3 fatty acid ratio. J. Nutr. Biochem. 9: 258-266.
• [73] Valeille K., Gripois D., Blouquit M-F., Souidi M., Riottot M., Bouthegourd J-Ch., Serougne C., Martin J.Ch. 2004. Lipid atherogenic risk markers can be more favourably influenced by the cis-9, trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. Brit. J. Nutr. 91: 191-199.
• [74] Visonneau S., Cesano A., Tepper S.A. 1997. Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res. 17: 969-973.
• [75] Voorrips L.E., Brants H.A.M., Kardinaal A.F.M., Hiddink G.J., van den Brandt P.A., Goldbohm R.A. 2002. Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands cohort study on diet and cancer. Am. J. Clin. Nutr. 76: 873-882.
• [76] Wahle K.W.J., Rotondo D., Heys S.D. 2003. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc. Nutr. Soc. 62: 349-360.
• [77] WHO 2004. Food and health in Europe: a new basis fraction. WHO. Copenhagen: 7-73.
• [78] WHO/FAO 2003. Diet nutrition and the prevention of chronic diseases. WHO. Geneve: 4-101.
• [79] Yamasaki M., Chujo H., Hirao A., Koyanagi N., Okamoto T., Tojo N., Oishi A., Iwata T., Yamauchi-Sato Y., Yamamoton T., Tsutsumi K., Tachibana H., Yamada K. 2003. Immunogobulin and cytokine production from spleen lymphocytes is modulated in C57BL/6J mice by dietary cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid. J. Nutr. 133: 784-788.
• [80] Yaqoob P. 2004. Fatty acids and the immune system: from basic science to clinical applications. Proc. Nutr. Soc. 63: 89-104.
• [81] Zapolska-Downar D. 2000. Dysfunkcja komórek śródbłonka jako jeden z czynników patogenetycznych miażdżycy. Normalizujący wpływ niektórych leków. Czynniki Ryzyka 4/00: 5-15.
• [82] Zapolska-Downar D. 2004. Mononuclear cell recruitment and inflammation in atherosclerosis. Vase. Dis. Prev. 1: 41-51.
• [83] Zock P.L., Katan M.B. 1998. Linoleic acid intake and cancer risk: a review and meta-analysis. Am. J. Clin. Nutr. 68: 142-153.